Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Market Potential of Carbon Dioxide Nasal Spray in Congested Subjects
NCT02113449Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2013
- Primary completion
- Feb 2014
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Carbon dioxide in nasal congestion, sponsored by GSK. Started Nov 2013; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
nasal congestion
Beyond the preview
Go deeper on NCT02113449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113449.